research use only
Cat.No.S1460
| Related Targets | ERK p38 MAPK Raf MEK Ras KRas S6 Kinase MAP4K TAK1 Mixed Lineage Kinase |
|---|---|
| Other JNK Inhibitors | CC-90001 JNK-IN-8 Anisomycin (Flagecidin) JNK Inhibitor IX Tanzisertib Hydrochloride (CC-930) JNK Inhibitor VIII Polyphyllin I BI-78D3 DTP3 SU3327 |
|
In vitro |
DMSO
: 60 mg/mL
(272.44 mM)
Water : Insoluble Ethanol : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about SP600125 working concentrations for cell culture treatment
| Information | SP600125 is a potent, selective, and reversible ATP-competitive JNK inhibitor. It affects JNK/c-Jun and MAPK signaling pathways by blocking JNK phosphorylation and c-Jun activation, effectively inhibiting inflammation, cell proliferation, and apoptosis in various cells. |
|---|---|
|
Read more about SP600125 IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 220.23 | Formula | C14H8N2O |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 129-56-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | Nsc75890 | Smiles | C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
how to reconstitute the inhibitor for in vivo studies?
Answer:
It can be dissolved in 5% DMSO/corn oil at 5 mg/ml as a clear solution for injection. For oral administration, this compound dissolved in vehicle 30% PEG400/0.5% Tween80/5%Propylene glycol, at 30mg/ml is a suspension and can be used.